|
|
||||||||
Rheumatology Section, Evans Memorial Department of Clinical Research and Department of Medicine, Boston University Medical Center, Boston, MA 02118
We have demonstrated that macrophages (M
) from young,
prediseased, lupus-prone MRL/++ and New Zealand Black/White
F1 mice display defective production of TNF-
, IL-1, and
IL-6, but normal production of IL-10. In an attempt to determine the
potential functional implications of this phenotype for autoimmunity,
we demonstrate here that endotoxin-activated M
from these
lupus-prone mice showed dramatically reduced expression of IL-12, a
cytokine essential for Th1 responses that may be defective during
lupus. IL-12 production was also reduced by M
from the control
BALB/c strain, compatible with the concept that a genetically
programmed deficit in IL-12 levels may underlie the IL-4-dominated
BALB/c response to infection by the parasite Leishmania
major. Although both IL-12 and TNF-
expression defects by
M
from lupus-prone strains are expressed rapidly after activation,
treatment with each cytokine demonstrated that only TNF-
contributes
to the subsequent dysregulation of M
IL-1 and IL-6 expression in
these strains, and that the reduced autocrine activity of defective
IL-12 or TNF-
levels was not causal to each other. Although the
intrinsic defect in IL-12 expression by lupus-prone and BALB/c M
may
lead to defective Th1 responses, these M
responded to the
Th1-derived cytokine, IFN-
, in a normal fashion suggesting a
defective role in the induction, rather than the propagation, of Th1
responses in these mice. Our finding of a conserved intrinsic defect in
IL-12 production by M
from the two principal mouse models of
multigenic lupus provides insight into how excessive humoral responses
may develop, and perhaps be prevented, in systemic autoimmune
disease.
This article has been cited by other articles:
![]() |
K Anam, M Amare, S Naik, K. Szabo, and T. Davis Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse Lupus, April 1, 2009; 18(4): 318 - 331. [Abstract] [PDF] |
||||
![]() |
L. M. Maier, S. K. Howlett, K. M. Rainbow, J. Clark, J. M. M. Howson, J. A. Todd, and L. S. Wicker NKG2D-RAE-1 Receptor-Ligand Variation Does Not Account for the NK Cell Defect in Nonobese Diabetic Mice J. Immunol., November 15, 2008; 181(10): 7073 - 7080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Zielinski, S. N. Jacob, F. Bouzahzah, B. E. Ehrlich, and J. Craft Naive CD4+ T Cells from Lupus-Prone Fas-Intact MRL Mice Display TCR-Mediated Hyperproliferation Due to Intrinsic Threshold Defects in Activation J. Immunol., April 15, 2005; 174(8): 5100 - 5109. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Charoenvit, G. T. Brice, D. Bacon, V. Majam, J. Williams, E. Abot, H. Ganeshan, M. Sedegah, D. L. Doolan, D. J. Carucci, et al. A Small Peptide (CEL-1000) Derived from the {beta}-Chain of the Human Major Histocompatibility Complex Class II Molecule Induces Complete Protection against Malaria in an Antigen-Independent Manner Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2455 - 2463. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma, K. Gee, W. Lim, K. Chambers, J. B. Angel, M. Kozlowski, and A. Kumar Dexamethasone Inhibits IL-12p40 Production in Lipopolysaccharide-Stimulated Human Monocytic Cells by Down-Regulating the Activity of c-Jun N-Terminal Kinase, the Activation Protein-1, and NF-{kappa}B Transcription Factors J. Immunol., January 1, 2004; 172(1): 318 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Simpson, M. S. Mistry, R. A. Maki, W. Yang, D. A. Schwarz, E. B. Johnson, F. M. Lio, and D. G. Alleva Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice J. Immunol., October 1, 2003; 171(7): 3333 - 3337. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu and D. I. Beller Distinct Pathways for NF-{kappa}B Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains J. Immunol., May 1, 2003; 170(9): 4489 - 4496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Potter, J. Cortes-Hernandez, P. Quartier, M. Botto, and M. J. Walport Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells J. Immunol., March 15, 2003; 170(6): 3223 - 3232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu and D. Beller Aberrant Production of IL-12 by Macrophages from Several Autoimmune-Prone Mouse Strains Is Characterized by Intrinsic and Unique Patterns of NF-{kappa}B Expression and Binding to the IL-12 p40 Promoter J. Immunol., July 1, 2002; 169(1): 581 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Alleva, E. B Johnson, F. M Lio, S. A Boehme, P. J Conlon, and P. D. Crowe Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-{gamma}: counter-regulatory activity by IFN-{gamma} J. Leukoc. Biol., April 1, 2002; 71(4): 677 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. B. Bastos, J. M. Alvarez, C. R. F. Marinho, L. V. Rizzo, and M. R. D'Imperio Lima Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile J. Leukoc. Biol., February 1, 2002; 71(2): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Koh, Z. Wang, and J. S. Levine Cytokine Dysregulation Induced by Apoptotic Cells Is a Shared Characteristic of Murine Lupus J. Immunol., October 15, 2000; 165(8): 4190 - 4201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill M-1/M-2 Macrophages and the Th1/Th2 Paradigm J. Immunol., June 15, 2000; 164(12): 6166 - 6173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Aronica, A Dozier, P Fanti, and M Nazareth Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin Lupus, May 1, 2000; 9(4): 271 - 277. [Abstract] [PDF] |
||||
![]() |
M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |